Is there any monitoring of the incidence of Creutzfeldt-Jakob disease in the United States?
Yes. The possibility that BSE can spread to humans has focused increased attention on the desirability of enhancing national surveillance for Creutzfeldt-Jakob disease (CJD) in the United States. The Centers for Disease Control and Prevention (CDC) monitors the trends and current incidence of CJD in the United States by analyzing death certificate information from U.S. multiple cause-of-death data, compiled by the National Center for Health Statistics, CDC. A summary of these data was published in the Journal of the American Medical Association on November 8, 2000 (Volume 284, No. 18, pp. 2322-3). and in Clinics of Laboratory Medicine in December 2002 (Volume 22, pp. 849-62). The average annual CJD death rate in the United States has remained relatively stable at about one case per million population per year. In addition, CJD deaths in persons aged <30 years in the United States remain extremely rare (<1 case per 100 million per year). In contrast, in the United Kingdom, over half of
